Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.

[1]  S. Klein,et al.  Biorelevant in vitro assessment of dissolution and compatibility properties of a novel paediatric hydrocortisone drug product following exposure of the drug product to child‐appropriate administration fluids , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  J. Breitkreutz,et al.  Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial , 2018, The Journal of pediatrics.

[3]  J. Breitkreutz,et al.  Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics , 2018, Journal of clinical pharmacology.

[4]  Helle Holst,et al.  Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered , 2018, Pharmaceutical Medicine.

[5]  E. Galella,et al.  Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop. , 2017, International journal of pharmaceutics.

[6]  B. Magnuson,et al.  Critical review of the current literature on the safety of sucralose. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  D. Fegley,et al.  Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients. , 2017, International journal of pharmaceutics.

[8]  S. Klein,et al.  Assessing the influence of media composition and ionic strength on drug release from commercial immediate‐release and enteric‐coated aspirin tablets , 2017, The Journal of pharmacy and pharmacology.

[9]  J. Walsh,et al.  Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations. , 2017, International journal of pharmaceutics.

[10]  Catherine Tuleu,et al.  The Milky Way: paediatric milk‐based dispersible tablets prepared by direct compression – a proof‐of‐concept study , 2017, The Journal of pharmacy and pharmacology.

[11]  H. Batchelor,et al.  Evidence of acceptability of oral paediatric medicines: a review , 2017, The Journal of pharmacy and pharmacology.

[12]  C. Tuleu,et al.  Medicines for children: flexible solid oral formulations , 2017, Bulletin of the World Health Organization.

[13]  Kristine Svinning Valeur,et al.  Safe excipient exposure in neonates and small children - protocol for the SEEN project. , 2017, Danish medical journal.

[14]  T. Egberts,et al.  Paediatric Drug Development and Formulation Design—a European Perspective , 2017, AAPS PharmSciTech.

[15]  V. Klingmann.  Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies , 2017, AAPS PharmSciTech.

[16]  S. Klein,et al.  Simulating Different Dosing Scenarios for a Child-Appropriate Valproate ER Formulation in a New Pediatric Two-Stage Dissolution Model , 2017, AAPS PharmSciTech.

[17]  D. V. van Riet-Nales,et al.  Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects , 2016, Archives of Disease in Childhood.

[18]  S. Klein,et al.  Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children. , 2016, Die Pharmazie.

[19]  Nicholas J. Andreas,et al.  Human breast milk: A review on its composition and bioactivity. , 2015, Early human development.

[20]  J. Breitkreutz,et al.  Acceptability of Uncoated Mini-Tablets in Neonates--A Randomized Controlled Trial. , 2015, The Journal of pediatrics.

[21]  C. Tuleu,et al.  Formulation factors affecting acceptability of oral medicines in children. , 2015, International journal of pharmaceutics.

[22]  Arzu Selen,et al.  Prediction of in‐vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in‐vitro–in‐silico–in‐vivo approach , 2015, The Journal of pharmacy and pharmacology.

[23]  Odon Planinšek,et al.  Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups , 2015, Expert opinion on drug delivery.

[24]  N. Fotaki,et al.  Paediatric oral biopharmaceutics: key considerations and current challenges. , 2014, Advanced drug delivery reviews.

[25]  Eva Schornick,et al.  Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms? , 2014, Pharmaceutical development and technology.

[26]  W. Weitschies,et al.  A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  H. Singh,et al.  Role of Sugar and Sugar Substitutes in Dental Caries: A Review , 2013, ISRN dentistry.

[28]  C. Tuleu,et al.  The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version. , 2013, International journal of pharmaceutics.

[29]  Diana A van Riet-Nales,et al.  Acceptability of different oral formulations in infants and preschool children , 2013, Archives of Disease in Childhood.

[30]  W. Weitschies,et al.  An Automated System for Monitoring and Regulating the pH of Bicarbonate Buffers , 2013, AAPS PharmSciTech.

[31]  Joshua R. Smith,et al.  Stability and physicochemical characterization of novel milk-based oral formulations. , 2013, International journal of pharmaceutics.

[32]  G. Pacifici.  Clinical Pharmacology of the Loop Diuretics Furosemide and Bumetanide in Neonates and Infants , 2012, Pediatric Drugs.

[33]  C. Tuleu,et al.  The STEP (safety and toxicity of excipients for paediatrics) database. Part 1-A need assessment study. , 2012, International journal of pharmaceutics.

[34]  J. Breitkreutz,et al.  Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  V. Fabiano,et al.  Paediatric pharmacology: remember the excipients. , 2011, Pharmacological research.

[36]  P. Macheras,et al.  Novel milk-based oral formulations: proof of concept. , 2010, International journal of pharmaceutics.

[37]  C. Tuleu,et al.  Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children , 2009, Pediatrics.

[38]  Jörg Breitkreutz,et al.  Paediatric and geriatric drug delivery , 2007, Expert opinion on drug delivery.

[39]  I. Johansson.  Milk and dairy products: possible effects on dental health , 2002 .

[40]  J. Prandota.  Clinical Pharmacology of Furosemide in Children: A Supplement , 2001, American journal of therapeutics.

[41]  J. B. Mielck,et al.  Minitabletting: improving the compactability of paracetamol powder mixtures , 1998 .

[42]  P. Chatterjee.  Pharmaceutical excipients and pediatric formulations , 2020 .

[43]  D. L. Munday.  A Comparison of the Dissolution Characteristics of Theophylline from Film Coated Granules and Mini-Tablets , 1994 .